The recommended adult dosage of oral KYTRIL (granisetron hydrochloride) is   2 mg once daily or 1 mg twice daily. In the 2 mg once-daily regimen, two 1 mg   tablets or 10 mL of KYTRIL (granisetron)  Oral Solution (2 teaspoonfuls, equivalent to 2 mg   of granisetron) are given up to 1 hour before chemotherapy. In the 1 mg twice-daily   regimen, the first 1 mg tablet or one teaspoonful (5 mL) of KYTRIL (granisetron)  Oral Solution   is given up to 1 hour before chemotherapy, and the second tablet or second teaspoonful   (5 mL) of KYTRIL (granisetron)  Oral Solution, 12 hours after the first. Either regimen is   administered only on the day(s) chemotherapy is given. Continued treatment,   while not on chemotherapy, has not been found to be useful.
No dosage adjustment is recommended (see CLINICAL    PHARMACOLOGY: Pharmacokinetics).
Safety and effectiveness in pediatric patients have not been established.
Radiation (Either Total Body Irradiation or Fractionated Abdominal Radiation)
The recommended adult dosage of oral KYTRIL (granisetron)  is 2 mg once daily. Two 1 mg tablets   or 10 mL of KYTRIL (granisetron)  Oral Solution (2 teaspoonfuls, equivalent to 2 mg of granisetron)   are taken within 1 hour of radiation.
Safety and effectiveness in pediatric patients have not been established.
No dosage adjustment is recommended.
